Lexaria Interest Expense from 2010 to 2024

LEXXW Stock  USD 0.75  0.04  5.63%   
Lexaria Bioscience Interest Expense yearly trend continues to be fairly stable with very little volatility. Interest Expense is likely to outpace its year average in 2024. Interest Expense is the cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit. View All Fundamentals
 
Interest Expense  
First Reported
2005-11-30
Previous Quarter
1
Current Value
1
Quarterly Volatility
40.5 K
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Lexaria Bioscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lexaria Bioscience's main balance sheet or income statement drivers, such as Depreciation And Amortization of 132.7 K, Interest Expense of 125.2 K or Other Operating Expenses of 3.2 M, as well as many indicators such as Price To Sales Ratio of 105, Dividend Yield of 0.0 or PTB Ratio of 54.87. Lexaria financial statements analysis is a perfect complement when working with Lexaria Bioscience Valuation or Volatility modules.
  
Check out the analysis of Lexaria Bioscience Correlation against competitors.

Latest Lexaria Bioscience's Interest Expense Growth Pattern

Below is the plot of the Interest Expense of Lexaria Bioscience Corp over the last few years. It is the cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit. Lexaria Bioscience's Interest Expense historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Lexaria Bioscience's overall financial position and show how it may be relating to other accounts over time.
Interest Expense10 Years Trend
Pretty Stable
   Interest Expense   
       Timeline  

Lexaria Interest Expense Regression Statistics

Arithmetic Mean111,344
Geometric Mean60,714
Coefficient Of Variation82.31
Mean Deviation70,964
Median114,329
Standard Deviation91,643
Sample Variance8.4B
Range265.1K
R-Value(0.16)
Mean Square Error8.8B
R-Squared0.03
Significance0.56
Slope(3,365)
Total Sum of Squares117.6B

Lexaria Interest Expense History

2024125.2 K
2023102.9 K
2021114.3 K
2020137.1 K
2019150.6 K
201859 K
201710.3 K

About Lexaria Bioscience Financial Statements

Lexaria Bioscience investors use historical fundamental indicators, such as Lexaria Bioscience's Interest Expense, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Lexaria Bioscience. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Interest Expense102.9 K125.2 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Lexaria Stock Analysis

When running Lexaria Bioscience's price analysis, check to measure Lexaria Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lexaria Bioscience is operating at the current time. Most of Lexaria Bioscience's value examination focuses on studying past and present price action to predict the probability of Lexaria Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lexaria Bioscience's price. Additionally, you may evaluate how the addition of Lexaria Bioscience to your portfolios can decrease your overall portfolio volatility.